Public BoD papers 26.5.22

The aim of research and innovation at The Christie is to enable every patient the opportunity to take part in research, to learn from every patient and to apply this knowledge to improve the lives of people with cancer now and in the future. We currently have 178 studies with Christie chief investigators and are lucky to have the NIHR Manchester Clinical Research Facility here at The Christie. In total over 4,000 patients were consented to trials leading to approximately 1,800 being recruited onto CRN portfolio studies, which is consistent with our pre Covid activity and is a real success for The Christie. Link to film can be found at https://twitter.com/NIHRCRN_gman/status/1526488234569740289 4. Fellow of The Academy of Medical Sciences Professor Timothy Illidge, Professor of Targeted Therapy and Oncology has been elected as a Fellow of The Academy of Medical Sciences. The Academy of Medical Sciences is the independent body in the UK representing the diversity of medical science. Their elected Fellows are the UK’s leading medical scientists from hospitals, academia, industry and the public service, all with a mission to advance biomedical and health research and its translation into benefits for society. Tim Illidge, Professor of Targeted Therapy and Oncology and Senior NIHR Investigator, works as a clinician scientist and his laboratory programme has been supported by CRUK for over 20 years. His laboratory has made discoveries in mechanisms of action of anti-CD20 antibodies, adaptive resistance to radiotherapy and overcoming this resistance with immunotherapy. In the clinic his research has changed clinical practice in Hodgkin and improved outcomes in Non-Hodgkin lymphoma. Further information can be found at https://blogs.bmh.manchester.ac.uk/blog/2022/05/17/academics-become-fellows-of- the-academy-of-medical-sciences/ 5. Senior Adult Oncology Unit As part of the Trust strategy, we committed to developing a dedicated ‘oncology of later life’ service to ensure our Trust meets the needs of an ageing population. We are delighted to announce that this goal will be achieved this summer, through the launch of our new multidisciplinary Senior Adult Oncology Unit led by Dr Fabio Gomes and supported during its implementation phase by the strategy department. This is a significant step forward, as despite being internationally recognised, only a small number of cancer centres around the world have a dedicated service to support this group of patients. The recruitment for this team (comprised of medics, nurses and AHPs) has been very successful so far and is due to be completed soon. This new outpatient-based service will support and benefit our growing population of older patients with frailty during anti-cancer treatments, promoting improvement in the care provided, as well as new opportunities for research and education. 6. Ramadan Celebrations Staff and patients at the Christie came together in April to celebrate the month of Ramadan. The Ethnic Diversity Group developed a number of initiatives aimed at providing staff and patients with support and to develop their understanding and awareness about the month of Ramadan. Many staff took part in a Nil by Mouth – Fasting Challenge, taking no food or water for over 16 hours. The fasting challenge invited staff from all faiths to experience fasting, spirituality and reflection for a day to show support for Muslim colleagues. Participants

14